Neuphoria Therapeutics Inc（NEUP）价格预测NEUPNeuphoria Therapeutics Inc

Alphio's NEUP stock price prediction model matches the current Neuphoria Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.99 (+5.25%). The 1-week path is $4.00 (+5.65%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Neuphoria Therapeutics is not a good buy right now due to significant financial instability and negative market sentiment. The stock has a current price of 3.76, a 1-year change of -68.54%, and an RSI of 30.433, indicating oversold conditions but also a lack of upward momentum. The recent halt in the development of a key Alzheimer's drug has led to a 19% drop in stock price, reflecting investor disappointment and uncertainty about future profitability. The main risk is the company's volatile earnings, with a recent net income loss of -9,906,504 in Q1 2026, which raises concerns about its financial health.

Neuphoria Therapeutics Inc (NEUP) last closed at $3.79, gaining +0.80%. These facts feed the 1-day and 1-week NEUP price prediction above.